DNA health company Pacific Biosciences raises $50M from Kleiner, others

Pacific Biosciences, formerly known as Nanofluidics, a Menlo Park, Calif. company focused on medications resulting from DNA gene sequencing, has raised around $50 million in a forth round of funding.

Investors include Maverick Capital, and return backers Alloy Ventures, Kleiner Perkins Caufield & Byers and Mohr, Davidow Ventures, according to PE Week, which first reported the funding today. Pacific Biosciences previously has raised more than $15M.

[aditude-amp id="flyingcarpet" targeting='{"env":"staging","page_type":"article","post_id":4835,"post_type":"story","post_chan":"none","tags":null,"ai":false,"category":"none","all_categories":"business,","session":"B"}']

Here is an article about its technology (free after registration).

(This story first posted 1/12)